Nitto Denko and Dainippon Sumitomo Pharma start phase II clinical trial of Ronasen (R), a percutaneous tape pharmaceutical preparation for schizophrenia treatment

Dainippon Sumitomo Pharma press release, July 27, 2012

Nitto Denko and Dainippon Sumitomo Pharma start phase II clinical trial of Ronasen (R), a percutaneous tape pharmaceutical preparation for schizophrenia treatment
Scroll to top